Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 9
2013 12
2014 10
2015 11
2016 24
2017 25
2018 36
2019 27
2020 44
2021 43
2022 22
2023 23
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
Le GH, Kwan ATH, Guo Z, Wong S, Badulescu S, Gill H, Teopiz KM, Meshkat S, Ceban F, Phan L, Subramaniapillai M, Di Vincenzo JD, Rosenblat JD, Mansur RB, d'Andrea G, Ho R, Rhee TG, McIntyre RS. Le GH, et al. Among authors: mansur rb. Acta Neuropsychiatr. 2024 Apr 12:1-7. doi: 10.1017/neu.2024.16. Online ahead of print. Acta Neuropsychiatr. 2024. PMID: 38605630
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. Le GH, et al. Among authors: mansur rb. J Affect Disord. 2024 Jun 15;355:342-354. doi: 10.1016/j.jad.2024.03.165. Epub 2024 Apr 1. J Affect Disord. 2024. PMID: 38570038 Review.
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS. Rosenblat JD, et al. Among authors: mansur rb. Med. 2024 Mar 8;5(3):190-200.e5. doi: 10.1016/j.medj.2024.01.005. Epub 2024 Feb 14. Med. 2024. PMID: 38359838 Clinical Trial.
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis.
Cha DS, Kleine N, Teopiz KM, Di Vincenzo JD, Ho R, Galibert SL, Samra A, Zilm SPM, Cha RH, d'Andrea G, Gill H, Ceban F, Meshkat S, Wong S, Le GH, Kwan ATH, Rosenblat JD, Rhee TG, Mansur RB, McIntyre RS. Cha DS, et al. Among authors: mansur rb. Expert Opin Pharmacother. 2024 Jan-Apr;25(1):5-14. doi: 10.1080/14656566.2023.2298340. Epub 2024 Feb 1. Expert Opin Pharmacother. 2024. PMID: 38164653 Review.
Psychotropic Drug-Related Weight Gain and Its Treatment.
McIntyre RS, Kwan ATH, Rosenblat JD, Teopiz KM, Mansur RB. McIntyre RS, et al. Among authors: mansur rb. Am J Psychiatry. 2024 Jan 1;181(1):26-38. doi: 10.1176/appi.ajp.20230922. Am J Psychiatry. 2024. PMID: 38161305 Review.
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
d'Andrea G, Pettorruso M, Di Lorenzo G, Rhee TG, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, Di Nicola M, Andriola I, Marcatili M, Clerici M, Dell'Osso BM, Sensi SL, Mansur RB, Rosenblat JD, Martinotti G, McIntyre RS. d'Andrea G, et al. Among authors: mansur rb. J Affect Disord. 2024 Mar 1;348:314-322. doi: 10.1016/j.jad.2023.12.038. Epub 2023 Dec 23. J Affect Disord. 2024. PMID: 38145840
239 results